Clinical Trial

Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy: A Randomized Controlled Trial in Taiwan.

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the impact of different discontinuation intervals of GLP-1 receptor agonists prior to colonoscopy on bowel preparation quality and the need for repeat colonoscopy, in order to establish appropriate discontinuation recommendations.
Trial Details
NCT Number NCT07736963
Lead Sponsor Fu Jen Catholic University Hospital
Conditions GLP-1
Enrollment 240 participants
Start Date 2026-06-01
Primary Completion 2027-06-01 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-30